Alpha Fusion

Unlock the potential of alpha-particle therapy for human health.

Osaka, Japan · $9.2M raised

Headquarters
Osaka
Employees
11–50
Business Model
B2B
Total Funding
$9.2M
Last Round
$9.2M Series BAug 2023
Rounds
1

About

Alpha Fusion Inc. is a Japan-based clinical-stage biotech company commercializing Targeted Alpha Therapy (TAT) based on astatine-211 (211At). The company integrates expertise in radiochemistry, drug discovery, and clinical medicine to develop innovative radiopharmaceuticals that destroy cancer cells with precision while minimizing damage to surrounding healthy tissue. Alpha Fusion has multiple pipelines leveraging astatine-211, with two programs currently in clinical trials and company-sponsored trials planned from 2026. The company collaborates with Osaka University, Mitsubishi Tanabe Pharma, and Veneno Technologies.

Summary

Alpha Fusion is a Biotechnology company based in Osaka, Japan. It has raised $9.2M in total across 1 round, most recently a $9.2M Series B round in Aug 2023.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BAug 2023
$9.2M

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alpha Fusion on Indexed.vc
<a href="https://indexed.vc/companies/alpha-fusion"><img src="https://indexed.vc/api/badge/company/alpha-fusion" alt="Alpha Fusion on Indexed.vc" width="260" height="76" /></a>